EFFICACY OF IPIDACRINE IN THE RECOVERY PERIOD OF ISCHAEMIC STROKE

dc.contributor.author	Sadriddin Sayfullaevich Pulatov
dc.date.accessioned	2025-12-31T15:35:56Z
dc.date.issued	2022-02-14
dc.description.abstract	Vascular diseases of the brain continue to be a major medical and social problem. According to WHO, approximately 5 million people die each year from cerebrovascular diseases. About 80% of people who suffer a stroke become disabled, 10% of whom become severely disabled and require ongoing care. Only 10% of strokes end in full recovery within the first weeks of illness
dc.format	application/pdf
dc.identifier.uri	https://scholarexpress.net/index.php/wbph/article/view/531
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/48833
dc.language.iso	eng
dc.publisher	Scholar Express Journals
dc.relation	https://scholarexpress.net/index.php/wbph/article/view/531/491
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	World Bulletin of Public Health; Vol. 7 (2022): WBPH; 28-32
dc.source	2749-3644
dc.subject	Ischaemic Stroke
dc.subject	Recovery Period
dc.subject	Ipidacrine
dc.subject	According
dc.title	EFFICACY OF IPIDACRINE IN THE RECOVERY PERIOD OF ISCHAEMIC STROKE
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: pulatov_2022_efficacy_of_ipidacrine_in_the_recovery_p.pdf
item.page.filesection.size: 168.52 KB
item.page.filesection.format: Adobe Portable Document Format